Early Onset Colorectal Cancer in Arabs, Are We Dealing with a Distinct Disease?

Author:

Al Zaabi Adhari1ORCID,Al Shehhi Asmaa2,Sayed Shaymaa2,Al Adawi Humaid3,Al Faris Faris4,Al Alyani Omaima4,Al Asmi Maitha5,Al-Mirza Abdulrahman1,Panchatcharam Sathiya6,Al-Shaibi Maha7

Affiliation:

1. College of Medicine and Health Sciences, Sultan Qaboos University, Muscat 123, Oman

2. Pathology Department, Sultan Qaboos University Hospital, Muscat 123, Oman

3. Surgery Department, Sultan Qaboos University, Muscat 123, Oman

4. Ministry of Health, Muscat 393, Oman

5. Ophthalmology Department, Oman Medical Specialty Board, Muscat 1422, Oman

6. Research & Studies Section, Oman Medical Specialty Board, Muscat 1422, Oman

7. Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat 123, Oman

Abstract

Early-onset colorectal cancer (EOCRC) incidence is increasing worldwide. Efforts are directed to understand the biological and clinical signatures of EOCRC compared to late-onset colorectal cancer (LOCRC). EOCRC is thought to present differently across different ethnic groups and geographical regions. This study was an attempt to contribute with data from the Arab world toward the understanding of the clinicopathological parameters of EOCRC compared to LOCRC. Data from 254 CRC patients diagnosed at Sultan Qaboos University Hospital from the period 2015–2020 were studied. About 32.6% of all diagnosed CRC patients are below 50 years old, with no differences in gender distribution between EOCRC and LOCRC (p-value 0.417). Rectal involvement and tumor laterality were comparable among the two groups. Adenocarcinoma accounts for 83.3% and 94.2% of EOCRC and LOCRC, respectively. More mucinous and signet ring adenocarcinoma (8.3% each) were reported in EOCRC than LOCRC (2.9% and 2.2%, respectively). MLH1 and PMS2 loss are more common among LOCRC, but MSH6 loss is more frequent in EOCRC. The overall survival of EOCRC and LOCRC was comparable (median survival 64.88 and 67.24 months, respectively). This study showed comparable clinicopathological parameters between EOCRC and LOCRC from Arabs, which adds to the bigger picture of understand the disease.

Funder

Deanship of Research, Sultan Qaboos University

Publisher

MDPI AG

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3